1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ashland's Board permanently appointed William Whitaker as Senior Vice President, Chief Financial Officer and Principal Financial Officer on July 18, 2025, after he had served as interim CFO since May 6, 2025. The filing sets his pay package, including a $414,600 base salary and a $1,100,000 initial equity grant.
Whitaker was named interim CFO effective May 6, 2025, and made permanent on July 18, 2025.
Base salary of $414,600, with a target annual incentive of 65% of base salary and long-term incentive award of up to 265% of base salary.
Initial equity grant with a fair market value of $1,100,000: 40% in RSUs vesting in three annual installments from November 20, 2026, and 60% in PSUs fully vesting on November 20, 2029.
Owens Corning said Roofing president Gunner Smith notified the company on July 16, 2025 that he will resign to pursue another opportunity. He moves to an executive consultant role effective July 21, 2025, and his employment ends August 8, 2025. The filing does not name a successor or discuss any financial effect.
Gunner Smith, President, Roofing and executive officer, gave notice on July 16, 2025 that he will resign to pursue another opportunity.
Smith transitions to executive consultant effective July 21, 2025.
His employment with the company terminates August 8, 2025.
The filing does not name a successor for the Roofing role.
AIG said John Neal, former CEO of Lloyd's of London, will join as President effective December 1, 2025, reporting to Chairman and CEO Peter Zaffino and leading the General Insurance organization. The filing sets his pay package, including a $1.25 million base salary and a $3.75 million target annual cash bonus, which gives shareholders a clear view of the cost of the appointment.
Start date: December 1, 2025; Neal reports to Chairman and CEO Peter Zaffino
Base salary of $1,250,000; target annual cash bonus of $3,750,000 with a guarantee of no less than target for 2025
Target annual equity award of $5,000,000; on start date, RSUs with initial grant value of $4,500,000 vesting over three years and a $2,700,000 cash payment
West Pharmaceutical Services appointed Robert McMahon, formerly CFO of Agilent Technologies, as Senior Vice President and Chief Financial Officer effective August 4, 2025, succeeding Bernard Birkett, who is retiring and will serve as Senior Advisor to the CEO through December 31, 2025. The filing discloses pay terms including an $800,000 base salary, a $3,115,000 sign-on bonus and a $4,200,000 replacement equity grant, which matter to shareholders as a change in the company's top finance role and a related compensation cost.
Robert McMahon becomes SVP and CFO effective August 4, 2025, overseeing finance, audit, treasury, tax, investor relations and procurement.
Offer terms include an $800,000 initial base salary and an annual bonus target of 80% of base salary.
One-time cash sign-on bonus of $3,115,000 and a replacement equity grant with a grant date fair value of $4,200,000.
LTI award with grant date fair value of $3,000,000 is scheduled for August 11, 2025.
United Natural Foods said Andre Persaud will no longer serve as its President and Chief Executive Officer, Retail, effective July 25, 2025, as part of its work to accelerate the retail business strategy. The separation is a qualifying termination, so he will receive severance under his 2023 Severance Agreement, and his outstanding equity awards will vest on a prorated basis.
Andre Persaud's role as President and CEO, Retail ends effective July 25, 2025
Severance Agreement is effective as of November 6, 2023; includes restrictive covenants and a release of claims
Outstanding equity awards vest on a prorated basis under the Amended and Restated 2020 Equity Incentive Plan
Amphastar Pharmaceuticals appointed David Gaugh as a Class I director on July 18, 2025, increasing the board from ten to eleven authorized seats. The board determined he is independent under Nasdaq listing standards, and he was not assigned to any committees at this time.
Board approved increase from 10 to 11 authorized directors on July 18, 2025
David Gaugh appointed Class I director, term runs to the 2026 annual meeting, effective immediately
Initial compensation: 50% restricted stock units and 50% stock options, aggregate grant date fair value of $260,000, vesting on first anniversary
Essential Properties Realty Trust (EPRT) expanded its board from seven to eight directors and elected Kristin L. Smallwood, a retired PricewaterhouseCoopers audit partner, effective July 15, 2025. The filing says the board considers her independent and a financial expert, and that seven of eight directors are now independent, which shareholders may view as a governance and financial-oversight addition.
Board increased from seven to eight directors effective July 15, 2025; Smallwood assigned to the audit committee
Smallwood was a PwC partner from 2006 until her retirement in 2025, with almost 30 years of audit experience
Director compensation includes an annual RSU award of $120,000 and annual cash retainer of $82,500, prorated, plus a $100,000 RSU award tied to her election
Company announced the election in a press release dated July 17, 2025
MillerKnoll said Chair Michael Volkema advised on July 15, 2025 that he will retire from the Board when his term ends at the 2025 annual shareholder meeting. He cited personal and family commitments and said the decision was not due to any disagreement with the company. The filing does not name a successor chair.
Michael Volkema advised the company on July 15, 2025 of his retirement from the Board
Retirement takes effect when his term ends at the 2025 annual meeting of shareholders
He previously served 9 years as President and CEO and 25 years as Board Chair
Filing states no disagreements with the company; no successor chair is named
Scholastic's board added two new independent directors, Milena Alberti and Anne Clark Wolff, effective July 16, 2025, and Alix Guerrier moved from the Common Shares seat to the Class A seat. Directors John L. Davies and David P. Young stepped down immediately, ahead of their planned retirements at the 2025 annual meeting. The changes refresh board membership and add financial and capital markets expertise, but the filing discloses no financial results or compensation changes beyond unchanged outside director pay for fiscal 2026.
Milena Alberti and Anne Clark Wolff were elected to the board effective July 16, 2025, to fill vacancies created by resignations.
John L. Davies and David P. Young resigned as directors on July 16, 2025, having planned to retire at the 2025 annual meeting.
Alix Guerrier resigned from his Common Share seat and was elected as a Class A director the same day.
Outside director pay is unchanged for fiscal 2026: $95,000 annual cash retainer and $125,000 in RSUs.
CenterPoint Energy appointed Jesus Soto Jr., currently an executive vice president at Quanta Services, as executive vice president and chief operating officer, effective August 11, 2025. He will oversee electric operations, gas operations, safety, supply chain and customer care, and report to CEO Jason Wells. The company also said it plans over $31 billion of investments over the next five years.
Soto's base salary is $725,000 per year, with a target short-term incentive of 80% of salary and a target long-term incentive of 260% of salary.
A buyout equity award of restricted stock units valued at $6 million vests 25% on each of the first four anniversaries of his start date.
The Board approved on July 17, 2025, an amendment letting officers at senior vice president level or higher defer up to 90% of salary and/or short-term incentive pay, effective January 1, 2026.
Dentsply Sirona said its board appointed Daniel Scavilla, a director since February 2025 and former Globus Medical CEO, as president and chief executive officer effective August 1, 2025, succeeding Simon Campion, who leaves on July 31, 2025. The company also issued preliminary second quarter 2025 results and reaffirmed its 2025 outlook, which gives shareholders a clearer view of the leadership transition and near-term results, though the filing gives no prior-year comparison.
Preliminary second quarter 2025 net sales are expected to be approximately $935 million, with adjusted EPS between $0.50 and $0.52.
The company reaffirmed its 2025 outlook from its May 8, 2025 earnings release and plans to report second quarter results on August 7, 2025.
Scavilla will receive an annual base salary of $1,030,000 and a target bonus of 135% of base salary; Campion resigned from the board effective July 20, 2025, reducing its size from eleven to ten members.
Sensata Technologies named Andrew Lynch as its Executive Vice President and Chief Financial Officer, effective immediately on July 21, 2025. Lynch had served as interim CFO since May 16, 2025, and has been with the company since 2009. The appointment makes permanent the leadership of all global financial activities, and his pay package is set out in the filing.
Lynch's base salary is $540,000 per year, with an annual cash bonus target of 100% of salary.
He receives a $600,000 equity grant, split 45% restricted stock units and 55% performance-based restricted stock units.
Lynch served as interim CFO from May 16, 2025, and previously led investor relations from 2024.
The full employment agreement will be filed with the Form 10-Q for the period ending June 30, 2025.
Daniel Scavilla resigned as Globus Medical's President, CEO and director effective July 18, 2025, to pursue another opportunity. The board named Keith Pfeil, the company's COO and CFO, as President and CEO and a director, and Kyle Kline as CFO, effective the same day. The company also reported preliminary second-quarter 2025 sales of approximately $745.3 million, up 18.4% as reported, and reaffirmed its full-year 2025 guidance.
Daniel Scavilla resigned as President, CEO and director effective July 18, 2025; the filing says the resignation was not due to any disagreement with the company.
Keith Pfeil was appointed President and CEO effective July 18, 2025, with his base salary rising to $490,000, prorated for 2025.
Preliminary Q2 2025 sales were approximately $745.3 million, up 18.4% as reported; base business sales were approximately $650.8 million, up 3.3%.
The company reaffirmed full-year 2025 revenue guidance of $2.80 billion to $2.90 billion and non-GAAP diluted EPS guidance of $3.00 to $3.30.
Moody's Corporation said director Lloyd W. Howell, Jr. notified the company on July 18, 2025 that he was resigning from its board of directors, effective immediately. The filing states the resignation was not due to any disagreement with the company's operations, policies or practices.
Director Lloyd W. Howell, Jr. resigned from the board effective immediately.
Resignation notice was given on July 18, 2025; the 8-K was filed July 21, 2025.
The filing states no disagreement with the company's operations, policies or practices.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.